Measurement of blood flow and xenon solubility coefficient in the human liver by xenon-enhanced computed tomography

Medical Physics

Volumn 39, Issue 12, 2012, Pages 7553-7559

  Sase, Shigeru ^a,b   Takahashi, Hideaki ^b   Shigefuku, Ryuta ^b   Ikeda, Hiroki ^b   Kobayashi, Minoru ^b   Matsumoto, Nobuyuki ^b   Suzuki, Michihiro ^b  

^a Anzai Medical Co Ltd   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

computed tomography; liver; xenon

Indexed keywords

APPROXIMATION ALGORITHMS; BIOPSY; BLOOD; HEMODYNAMICS; LIVER; SOLUBILITY; TISSUE; XENON;

ARTERIAL BLOOD; GOOD CORRELATIONS; HEPATIC TISSUE; LIVER BIOPSIES; NON-ALCOHOLIC STEATOHEPATITIS; OSTWALD SOLUBILITY; QUANTITATIVE STUDY; VENOUS BLOODS;

COMPUTERIZED TOMOGRAPHY;

EID: 84870889166     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.4767759     Document Type: Article

References (32)

1. D. Gur, W. F. Good, D. L. Herbert, H. Yonas, P. Wozney, D. H. Van Thiel, and S. K. Wolfson, Jr., Blood flow mapping in the human liver by the xenonCT method., J. Comput. Assist. Tomogr. 9, 447-450 (1985). 10.1097/00004728- 198505000-00004
2. K. A. Miles, M. P. Hayball, and A. K. Dixon, Functional images of hepatic perfusion obtained with dynamic CT., Radiology 188, 405-411 (1993).
3. S. Sase, M. Monden, H. Oka, K. Dono, T. Fukuta, and I. Shibata, Hepatic blood flow measurements with arterial and portal blood flow mapping in the human liver by means of xenon CT., J. Comput. Assist. Tomogr. 26, 243-249 (2002). 10.1097/00004728-200203000-00014
4. A. Fick, Ueber die messung des blutquantums in den herzventrikeln., Verh. Dtsch. Phys. Med. Ges. 2, 16-17 (1870)
5. quoted in its entirety by H. E. Hoff and H. J. Scott, Medical progress-physiology., N. Engl. J. Med. 239, 122-123 (1948).
6. B. P. Drayer, S. K. Wolfson, O. M. Reinmuth, M. Dujovny, M. Boehnke, and E. E. Cook, Xenon enhanced CT for analysis of cerebral integrity, perfusion, and blood flow., Stroke 9, 123-130 (1978). 10.1161/01.STR.9.2.123
7. F. Kelcz, S. K. Hilal, P. Hartwell, and P. M. Joseph, Computed tomographic measurement of the xenon brain-blood partition coefficient and implications for regional cerebral blood flow., Radiology 127, 385-392 (1978).
8. J. S. Meyer, L. A. Hayman, M. Yamamoto, F. Sakai, and S. Nakajima, Local cerebral blood flow measured by CT after stable xenon inhalation., Am. J. Roentgenol. 135, 239-251 (1980).
9. D. Gur, W. F. Good, S. K. Wolfson, Jr., H. Yonas, and L. Shabason, In vivo mapping of local cerebral blood flow by xenon-enhanced computed tomography., Science 215, 1267-1268 (1982). 10.1126/science.7058347
10. W. A. Kalender, A. Polacin, H. Eidloth, S. Kashiwagi, T. Yamashita, and S. Nakano, Brain perfusion studies by xenon-enhanced CT using washinwashout study protocols., J. Comput. Assist. Tomogr. 15, 816-822 (1991). 10.1097/00004728-199109000-00017
11. A. Steward, P. R. Allott, A. L. Cowles, and W. W. Mapleson, Solubility coefficients for inhaled anaesthetics for water, oil and biological media., Brit. J. Anaesth. 45, 282-293 (1973). 10.1093/bja/45.3.282
12. M. R. Charlton, J. M. Burns, R. A. Pedersen, K. D. Watt, J. K. Heimbach, and R. A. Dierkhising, Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States., Gastroenterology 141, 1249-1253 (2011). 10.1053/j.gastro.2011.06.061
13. S. S. Kety, The theory and applications of the exchange of inert gas at the lungs and tissues., Pharmacol. Rev. 3, 1-41 (1951).
14. G. von Oettingen, B. Bergholt, M. Rasmussen, L. Ostergaad, and J. Astrup, Pulmonary function affects the quantification of rCBF by non-invasive xenon methods., J. Neurosci. Methods 95, 159-169 (2000). 10.1016/S0165-0270(99)00179-X
15. N. Veall and B. L. Mallett, The partition of trace amounts of xenon between human blood and brain tissues at 37 °C., Phys. Med. Biol. 10, 375-380 (1965). 10.1088/0031-9155/10/3/306
16. S. Sase, H. Takahashi, H. Ikeda, M. Kobayashi, N. Matsumoto, and M. Suzuki, Determination of time-course change rate for arterial xenon using the time course of tissue xenon concentration in xenon-enhanced computed tomography., Med. Phys. 35, 2331-2338 (2008). 10.1118/1.2912021
17. C. V. Greenway and R. D. Stark, Hepatic vascular bed., Physiol. Rev. 51, 23-65 (1971).
18. R. Sarper, W. A. Fajiman, E. B. Rypins, J. M. Henderson, Y. A. Tarcan, J. T. Galambos, and W. D. Warren, A noninvasive method for measuring portal venoustotal hepatic blood flow by hepatosplenic radionuclide angiography., Radiology 141, 179-184 (1981).
19. R. T. Mathie, Hepatic blood flow measurement with inert gas clearance., J. Surg. Res. 41, 92-110 (1986). 10.1016/0022-4804(86)90014-4
20. V. Gülberg, K. Haag, M. Rössle, and A. L. Gerbes, Hepatic arterial buffer response in patients with advanced cirrhosis., Hepatology 35, 630-634 (2002). 10.1053/jhep.2002.31722
21. R. Longo, C. Ricci, F. Masutti, R. Vidimari, L. S. Crocé, L. Bercich, C. Tiribelli, and L. D. Palma, Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography., Invest. Radiol. 28, 297-302 (1993). 10.1097/00004424-199304000-00006
22. C. Ricci, R. Longo, E. Gioulis, M. Bosco, P. Pollesello, F. Masutti, L. S. Crocé, S. Paoletti, B. Bernard, C. Tiribelli, and L. D. Palma, Noninvasive in vivo quantitative assessment of fat content in human liver., J. Hepatol. 27, 108-113 (1997). 10.1016/S0168-8278(97)80288-7
23. M. R. Oliva, K. J. Mortele, E. Segatto, J. N. Glickman, S. M. Erturk, P. R. Ros, and S. G. Silverman, Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation., J. Comput. Assist. Tomogr. 30, 37-43 (2006). 10.1097/01.rct.0000193818.31749.84
24. L. S. Szczepaniak, P. Nurenberg, D. Leonard, J. D. Browing, J. S. Reingold, S. Grundy, H. H. Hobbs, and R. L. Dobbins, Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population., Am. J. Physiol. Endocrinol. Metab. 288, E462-E468 (2005). 10.1152/ajpendo.00064.2004
25. H. Becker, M. Knoll, B. Haubitz, and K. L. Rittmann, Radiation exposure., in Quantitative Cerebral Blood Flow Measurements Using Stable XenonCT: Clinical Applications, edited by, M. Tomonaga, A. Tanaka, and, H. Yonas, (Futura, New York, 1995), pp. 55-60.
26. I. Suramo, M. Päivänsalo, and V. Myllylä, Cranio-caudal movements of the liver, pancreas and kidneys in respiration., Acta Radiol. Diagn. (Stockh) 25, 129-131 (1984).
27. R. Wagman, E. Yorke, E. Ford, P. Giraud, G. Mageras, B. Minsky, and K. Rosenzweig, Respiratory gating for liver tumors: Use in dose escalation., Int. J. Radiat. Oncol. Biol. Phys. 55, 659-668 (2003). 10.1016/S0360-3016(02)03941-X
28. J. P. Kühn, M. Evert, N. Friedrich, S. Kannengiesser, J. Mayerle, R. Thiel, M. M. Lerch, F. Dombrowski, B. Mensel, N. Hosten, and R. Puls, Noninvasive quantification of hepatic fat content using three-echo dixon magnetic resonance imaging with correction for T2 relaxation effects., Invest. Radiol. 46, 783-789 (2011). 10.1097/RLI.0b013e31822b124c
29. S. B. Reeder, I. Cruite, G. Hamilton, and C. B. Sirlin, Quantitative assessment of liver fat with magnetic resonance and spectroscopy., J. Magn. Reson. Imaging 34, 729-749 (2011). 10.1002/jmri.22580
30. D. A. Raptis, M. A. Fischer, R. Graf, D. Nanz, A. Weber, W. Moritz, Y. Tian, C. E. Oberkofler, and P. A. Clavien, MRI: The new reference standard in quantifying hepatic steatosis, Gut 61, 117-127 (2011). 10.1136/gutjnl-2011- 300155
31. J. Ong, Z. M. Younossi, V. Raddy, L. L. Price, J. Mayes, and N. Boparai, Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease., Liver Transpl. 7, 797-801 (2001). 10.1053/jlts.2001.24644
32. S. Ijaz, W. Yang, M. C. Winslet, and A. M. Seifalian, Impairment of hepatic microcirculation in fatty liver., Microcirculation 10, 447-456 (2003). 10.1038/sj.mn.7800206